Lipid-based nanoparticles provide new hope for patients awaiting sarcoma treatments

Research led by students at the Medical College of Georgia at Augusta University is presenting a new approach to tackling sarcoma, an incurable bone disease that impacts children and teens.
Research results in a study published in the journal Biomaterials Science and Technology.
As bone cells become heavy, they can no longer dial down the mechanical force generated in the femur bone to dial down the stress on the skin. Continue reading

Read more

Controversial multi-billion-dollar health insurance project stops payouts to doctors

The Network, which was due to pay millions in health care consultants, nurses and technology workers, had been due to spend $1.5 billion.
Linda Hall is world-renowned in child and adolescent psychiatry, and wants to work with Australian Red Cross to fight violence against children in detention centres.
“I’m embarrassed to admit I felt threatened by the prospect of one more year at a rate of $200 a month. Continue reading

Read more

New class of cancer immunotherapy inhibitors offers potential as treatment targets

The research indicates that the new targetable cells have the potential to reduce relapse in patients with solid tumors.
For more than 20 years, Sigmund Hultqvist, Stockholm University bioengineer, has worked with his colleague Karl theodorou to develop new cancer-targeting immunotherapies.
Among the most successful obstacles have been the observed effect in cancer cells.
The research, conducted with colleagues in Finland and Japan and funded by Sigmund’s lab in Stockholm, Sweden, has just been published in Trends in Immunology (TIM) and will be extended into high-throughput screening and clinical trials. Continue reading

Read more